J. Gibson Lanier, PhD

J. Gibson Lanier is a member of the biotechnology, medical technology, and pharmaceutical practice teams in Ballard Spahr's Patents Group. Dr. Lanier has extensive experience in immunology and microbiology working with multiple bacterial, parasitic, and viral infectious systems. Additionally, his research focused on T and B cell memory and effector responses, identifying a novel pre-plasma cell population in the process. Dr. Lanier has applied his knowledge of inventions associated with molecular biology, infectious disease, immunological responses, cancer treatments, stem cells, and vaccine development to his legal practice.

Dr. Lanier's experience encompasses all aspects of foreign and domestic patent prosecution, interference proceedings, and post-issuance reissue and reexamination. He also prepares and evaluates licensing agreements, non-infringement, invalidity, patentability, and freedom to operate opinions as well as counsels clients in due diligence matters. Representative technologies include vaccines, DNA and protein therapeutics, antibodies, diagnostic assays, immunological screens, biomarkers, transgenic animals, surgical devices, gene therapy, molecular and cellular biological screening assays, and peptide/protein therapy.

Professional Activities

State Bar of Georgia
Intellectual Property Section, Patent Committee

Atlanta Bar Association

American Intellectual Property Law Association

American Association for the Advancement of Science

Association of University Technology Managers

Publications

Co-author, "Memory CD8 T-cell compartment grows in size with immunological experience." Nature. 2009 Jan 8; 457(7226): 196-9

Co-author, "Localization of CD8+ cells specific for hepatitis B virus surface protein in the liver of immunized mice." J. Med. Virol. 2008 Feb; 80(2):225-32.

Co-author, "Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation." Virology. 2003 Oct 10; 315(1):93-102.

Co-author, "Heterologous immunity provides a potent barrier to transplantation tolerance." J. Clin. Invest. 2003 Jun; 111(12):1887-95.

Co-author, "Mitochondrial potential and reactive oxygen intermediates in antigen-specific CD8(+) T cells during viral infection." J. Immunol. 2003 May 1; 170(9):4745-51.

Co-author, "Differential Expansion and Death of Naïve and Memory Cells." J. Immunol. 2002 Oct 1; 169(7):3760-70.

Co-author, 2001. "Role of LTa in T cell responses during an acute virol infection." J. Virol. 2002 Apr; 76(8):3943-51.

Co-author, 2001. "Immunological Memory to Infection. In Immunology of Infectious Diseases." Stefan H.E. Kaufman, Alan Sher and Rafi Ahmed (eds.), ASM Press, Washington, D.C.

Co-author, 2001. "Expansion and death of antigen specific T cells proceeds normally in the absence of tumor suppressor." p. 53. J. Immunol. 167:1333-1337.

Co-author, 2001. "Altered lymphocyte responses and cytokine production in mice deficient in the x-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. PNAS." 98(13). 7449-7454.

Co-author, 1999. "Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses." Vaccine. 18(5-6):549-57.

Speaking Engagements

Georgia State University School of Law, guest lecturer, patent law, annually since 2008

Mercer University School of Law, guest lecturer, patent law, annually since 2008

"The Effect of the America Invents Act on Small Businesses," University of Rochester F.I.R.E lecture series, May 2012

"Leahy-Smith, America Invents Act," University of Central Florida, January 2012

"Patenting Basics – The America Invents Act," University of Rochester F.I.R.E lecture series, November 2011

"Leahy-Smith, America Invents Act," Biotechnology Association of Alabama, November 2011

"Leahy-Smith, America Invents Act," HudsonAlpha Institute seminar, November 2011

"Inequitable Conduct – Therasense, Inc. v. Beckton Dickinson & Co.," University of Rochester F.I.R.E series lectures, April 2011

"Giving Away the Farm – Why Material Transfer Agreements Matter in a University Setting," University of Rochester F.I.R.E lecture series, November 2009

"Reality IP: Why Patents Matter in the University Setting," University of Rochester F.I.R.E lecture series, June 2003

Georgia State University College of Law (J.D. 2008)

Emory University (Ph.D., microbiology and immunology, 2001)

University of Alabama at Birmingham (B.S. 1993)

Georgia

U.S. Patent and Trademark Office

U.S. District Court for the Middle District of Georgia